Serious Adverse Events Reporting in Phase III Randomized Clinical Trials of Colorectal Cancer Treatments: A Systematic Analysis

Objective: The occurrence, development, and prognosis of serious adverse events (SAEs) associated with anticancer drugs in clinical trials have important guiding significance for real-world clinical applications. However, to date, there have been no studies investigating SAEs reporting in randomized...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Yanhong, Liu, Zhentao, Zhang, Hua, Li, Jian, Peng, Zhi, Yu, Jinyu, Cao, Baoshan, Shen, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636814/
https://www.ncbi.nlm.nih.gov/pubmed/34867369
http://dx.doi.org/10.3389/fphar.2021.754858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636814/
https://www.ncbi.nlm.nih.gov/pubmed/34867369
http://dx.doi.org/10.3389/fphar.2021.754858

Ejemplares similares